AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Unusual Whales
Secured a $15.3 million funding through milestone warrants, which may also generate up to $34.0 million in total gross proceeds. This financial boost will aid in the ongoing progress of the ABP-450 development program.